Journal article
Cannabinoid polymorphisms interact with plasma endocannabinoid levels to predict fear extinction learning
LJ Ney, A Matthews, CMK Hsu, DV Zuj, E Nicholson, T Steward, D Nichols, B Graham, B Harrison, R Bruno, K Felmingham
Depression and Anxiety | WILEY | Published : 2021
DOI: 10.1002/da.23170
Abstract
Background: The endocannabinoid system is gaining increasing attention as a favorable target for improving posttraumatic stress disorder (PTSD) treatments. Exposure therapy is the gold-standard treatment for PTSD, and fear extinction learning is a key concept underlying successful exposure. Methods: This study examined the role of genetic endocannabinoid polymorphisms in a fear extinction paradigm with PTSD compared to healthy participants (N = 220). Participants provided saliva for genotyping, completed a fear conditioning and extinction task, with blood samples taken before and after the task (n = 57). Skin conductance was the outcome and was analyzed using mixed models. Results: Results f..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
National Health and Medical Research Council, Grant/Award Number: APP1073041